677 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

MRKR

Marker Therapeutics
US$4.11-6.6%202.2%US$36.1mUS$11.00PS11.1xE-5.2%n/a

AUTL

Autolus Therapeutics
US$4.00-5.0%104.1%US$978.6mUS$10.54PS626.4xE52.4%n/a

QSAM

QSAM Biosciences
US$7.75-6.1%31.4%US$34.7mn/aPB211.2xn/an/a

VIRI

Virios Therapeutics
US$0.443.5%-52.7%US$8.7mUS$2.20PB2.2xE-4.2%n/a

GRI

GRI Bio
US$0.42-1.4%-99.1%US$1.4mn/aPB5.2xn/an/a

NBSE

NeuBase Therapeutics
US$0.42-5.9%-87.9%US$1.6mn/aPB0.1xn/an/a

CYTH

Cyclo Therapeutics
US$1.4512.4%8.2%US$41.6mUS$3.20PS38.7xE53.3%n/a

SHPH

Shuttle Pharmaceuticals Holdings
US$0.437.7%-68.1%US$7.2mn/aPB1.8xn/an/a

ZTS

Zoetis
US$158.505.1%-10.8%US$72.8bUS$213.93PE30.9xE7.9%1.1%

RUBY

Rubius Therapeutics
US$0.0572.7%-64.4%US$5.2mn/aPB0.3xn/an/a

AMTI

Applied Molecular Transport
US$0.26-11.0%-26.2%US$10.9mn/aPB0.7xn/an/a

FRLN

Freeline Therapeutics Holdings
US$6.48-0.2%-21.7%US$28.3mUS$8.25PS45.4xE60.7%n/a

GTH

Genetron Holdings
US$4.030.1%37.6%US$127.3mn/aPS1.4xn/an/a

SNES

SenesTech
US$0.793.5%-95.0%US$3.9mUS$3.50PS3.4xE16.9%n/a

CLNN

Clene
US$0.4429.7%-53.1%US$55.5mUS$5.00PS85.8xE54.8%n/a

ICLR

ICON
US$301.61-2.5%62.4%US$24.6bUS$354.14PE36.5xE14.1%n/a

ADTX

Aditxt
US$2.411.7%-90.0%US$4.0mn/aPS6.2xn/an/a

EDSA

Edesa Biotech
US$4.453.3%-43.2%US$14.3mUS$24.00PB2.4xE-20.6%n/a

CYCN

Cyclerion Therapeutics
US$3.049.7%-43.1%US$7.2mn/aPB0.7xn/an/a

LIXT

Lixte Biotechnology Holdings
US$2.88-12.2%-47.7%US$6.2mn/aPB13.1xn/an/a

ANEB

Anebulo Pharmaceuticals
US$2.966.1%28.1%US$75.2mUS$6.00PB11.8xE9.9%n/a

IONS

Ionis Pharmaceuticals
US$43.011.3%23.8%US$6.0bUS$58.13PS8xE32.5%n/a

RGNX

REGENXBIO
US$16.201.0%-19.9%US$752.8mUS$39.83PS8.8xE35.5%n/a

HEPA

Hepion Pharmaceuticals
US$1.363.0%-89.5%US$7.5mUS$30.00PB1.3xE-33.4%n/a
Page 27 of 29
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.